TITLE

Promising prostate test

AUTHOR(S)
Brink, Susan; Mannix, Margaret
PUB. DATE
June 1994
SOURCE
U.S. News & World Report;6/27/94, Vol. 116 Issue 25, p79
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that a simple blood test may soon help prostate cancer patients decide if surgery will help them. The new test, described in the June 1994 issue of the journal `Urology,' is the first application of molecular technology to assess the spread of cancer. Details of the test called reverse transcriptase polymerase chain reaction; Percentage of false-positive readings; Where test is available on an experimental basis.
ACCESSION #
9406227989

 

Related Articles

  • Early prostate cancer best left alone--Treatment riskier than cancer.  // HealthFacts;Jul93, Vol. 18 Issue 170, p1 

    Reports on the modalities of treating prostatic cancer. Prostate Patient Outcomes Research Team; Radical prostatectomy; Prostate-specific antigen blood test; Radiation therapy; Watchful waiting; Nerve-sparing technique.

  • Patients say they want aggressive treatment for prostate cancer.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p31 

    Reports that a Harris Poll survey of 1,000 newly diagnosed patients has found that men who have prostate cancer want the most aggressive therapy available. Other survey results.

  • Prostate-cancer vaccine.  // Men's Health;Jul/Aug97, Vol. 12 Issue 6, p126 

    Presents information about prostate-cancer vaccine. Effectivity of the vaccine; Effect of a cancerous prostate cells left after surgery; Testing the vaccine in patients whose cancer has returned after surgery.

  • PSA results refute objections to perineal prostatectomy. Kuznar, Wayne // Urology Times;Jan95, Vol. 23 Issue 1, p22 

    Reports on the effectiveness of radical prostatectomy as a treatment for localized prostate cancer as indicated by postoperative prostate-specific antigen (PSA) levels. Criticism of perineal approach; Retropubic approach; Limiting factor to radical perineal prostatectomy.

  • Sr 89 injection eases prostate cancer pain.  // Urology Times;Dec95, Vol. 23 Issue 12, p17 

    Reports on an article published in the June 1993 issue of `Seminars in Oncology' about a drug that reduces the pain experienced by prostate cancer patients.

  • Concern grows over prostate cancer treatment options. Parkins, Troy // JNCI: Journal of the National Cancer Institute;6/15/94, Vol. 86 Issue 12, p897 

    Reports on the benefits and limitations of various treatment options for prostate cancer. Popularity of radical prostatectomy; Effectiveness of cryosurgery over radiation; Concerns of doctors on cryosurgery; Side effects of prostate cancer treatment.

  • Inhibition of prostate cancer metastasis: A critical challenge ahead. Linehan, W. Marston // JNCI: Journal of the National Cancer Institute;3/1/95, Vol. 87 Issue 5, p331 

    Editorial. Observes that there is no curative therapy for prostate cancer once it spreads beyond the prostate. Challenge to develop agents that will inhibit or prevent progression of recurrent or locally advanced prostate cancer; Investigation into the ability of naturally occurring agents.

  • Cancer treatment options.  // USA Today Magazine;Oct95, Vol. 124 Issue 2605, p3 

    Describes three treatment options that can be used by prostate cancer patients, urologists and radiation oncologists. Monitoring of early cancers; Removal of the prostate by radical prostatectomy; Methods of radiation therapy; Clinical trials to improve existing treatment options.

  • Is bad press on prostate cancer treatment undermining urologists? Nash, Karen // Urology Times;May96, Vol. 24 Issue 5, p30 

    Discusses the effect of negative reports published in the United States concerning the screening and treatment methods for prostate cancer on the urology practice. Reaction of urologists about federal government-sponsored reports; Allegation that the federal government has ulterior motives in...

  • Finasteride does not reduce PSA's role in prostate cancer detection. Bankhead, Charles // Urology Times;Oct98, Vol. 26 Issue 10, p1 

    Deals with the findings of the Proscar Long-Term Efficacy and Safety Study that treatment of BPH with finasteride does not reduce the effectiveness of PSA testing for prostate cancer. Details on the study; PSA levels reduced by finasterides; Comments on the findings of the study.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics